Multiple Myeloma Symposium: Future of Treatment | Dana-Farber Cancer Institute

Paul G. Richardson, MD, clinical program leader and director of clinical research, the Jerome Lipper Multiple Myeloma Center and LeBow Institute for Myeloma Therapeutics at Dana-Farber Cancer Institute, gives a clinical perspective on the future of multiple myeloma treatments. This presentation was originally given at the Multiple Myeloma Patient Education Symposium on Dec. 13, 2014 in Boston, MA. Learn more about Dana-Farber’s research and treatment for multiple myeloma at

Category: News
About The Author